The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced central ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced ...

Wet macular degeneration is a specific subtype of age ... These tests may also be used to assess your response to treatment. Fluorescein angiogram: A fluorescent dye is injected into your arm ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

For every 10 people who have macular degeneration, one or two will get wet AMD. But spotting the wet AMD symptoms early will help you get treatment and prevent vision loss. Blurry vision or other ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...